Rituximab Biosimilar Immunological Preparation from United States
A mixed immunological preparation containing rituximab monoclonal antibodies, used to treat non-Hodgkin lymphoma and rheumatoid arthritis. It is not put up in measured doses or for retail sale, so it falls under tariff item 3002.14.00.
Duty Rate — United States → Canada
0%
Import Tips
• Ensure the product is in bulk form, not packaged for retail sale, to qualify for this tariff item
• Have documentation showing the rituximab content and that it is mixed, as per Chapter 30 Note 2
• Verify if a Drug Identification Number (DIN) is required by Health Canada before import